Avon Foundation for Women
Breast Cancer Research Program
The Avon Foundation for Women continues to seek new preventive strategies to address the growing number of breast cancer cases around the globe. To develop new strategies to prevent breast cancer we need to understand the causes of breast cancer in women, changes in breast cells that give rise to cancer, markers for disease, and how breast cancer progresses. The 2011 Avon Foundation Research Program seeks proposals in these areas to advance understanding of causes of breast cancer and prevention.
Amount: $300,000 to cover 2 years
Deadline: May 6, 2011 for LOI
Ovarian Cancer Research Fund
Program Project Development Grants
Provide funds for ovarian cancer research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions.
Amount: $900,000 over 3 years
Deadline: LOI due May 9, 2011
Ovarian Cancer Research Fund
Liz Tilberis Scholars Awards
For junior investigators in their first academic faculty appointment. This award is open to physician-scientists (Gynecologic Oncology, Medical Oncology) and Ph.D. scientists.
Amount: $450,000 over 3 years
Deadline: LOI due May 9, 2011
Ovarian Cancer Research Fund
Ann Schreiber Research Training Programs of Excellence Grant Funds post-doctoral trainees (Gynecologic Oncology or Medical Oncology fellows or Ph.D.s) who are working in established ovarian cancer research groups.
Amount: $75,000 to be used over 1-2 years
Deadline: LOI due May 9, 2011
Bill and Melinda Gates Foundation
Grand Challenges in Global Health
This is an initiative to encourage innovative and unconventional global health solutions. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies. Grant proposals are being accepted on the following topics: Explore Nutrition for Healthy Growth of Infants and Children; Apply Synthetic Biology to Global Health Challenges; The Poliovirus Endgame: Create Innovative Ways to Accelerate, Sustain, and Monitor Eradication; Create the Next Generation of Sanitation Technologies; Design New Approaches to Cure HIV Infection; Create Low-Cost Cell Phone-Based Solutions for Improved Uptake and Coverage of Childhood Vaccinations
Amount: $100,000
Deadline: May 19, 2011
Damon Runyon Cancer Foundation
Damon Runyon-Rachleff Innovation Award
The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high risk/high reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.
**applications will be accepted from all scientific disciplines (e.g., Chemistry, Computer Sciences, Mathematics, Engineering, Physics-not just biomedical) provided that the proposed research meets the selection criteria.
Amount: $150,000/year for 3 years
Deadline: Pre-proposal due June 1, 2011
The Cure Starts Now Foundation
Research Grants Program
The Foundation seeks to fund research investigating cures for pediatric brain cancers with a focus on Diffuse Intrinsic Brainstem Glioma (DIPG). The focus is to support translational and clinical research projects in those areas.
Amount: $100,000 for one year
Deadline: June 1, 2011
The Doctors Cancer Foundation
Nolan Miller Grant - lung cancer only
Awarded to the best program for management of lung cancer. There is a strong interest in cancer stem cells, microRNAi agents, epigenetic agents, as well as many others. The foundation is particularly interested in promoting the best of the young scientists, currently under the radar screen. Foundation is not looking at studies that show that drug A is 3% better than drug B. The project should be innovative, sound, and be able to lead to clinical trials.
Amount: $50,000
Deadline: June 30, 2011
The Doctors Cancer Foundation
Nolan Miller Grant Awarded to the best program for the management
other than lung cancer. There is a strong interest in cancer stem cells, microRNAi agents, epigenetic agents, as well as many others. The foundation is particularly interested in promoting the best of the young scientists, currently under the radar screen. Foundation is not looking at studies that show that drug A is 3% better than drug B. The project should be innovative, sound, and be able to lead to clinical trials.
Amount: $50,000
Deadline: June 30, 2011
Breast Cancer Alliance
Young Investigator Grants
The Breast Cancer Alliance invites clinical doctors and research scientists whose primary focus is breast cancer who have been appointed to a position equivalent to Assistant Professor within three years following the appointment, to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions within a 200 miles radius of Greenwich, Connecticut (an area that includes cities such as Boston, Philadelphia, New York City, Hartford, and Albany).
Amount: $125,000 over 2 years
Deadline: July 31, 2011
Uniting Against Lung Cancer
Legacy Program for Advances in Lung Cancer Research
In 2011, this foundation is prioritizing innovative, high risk/high reward research. They aim to jumpstart new projects
leading to improved treatments and a cure for lung cancer, including non-small cell and small cell lung cancer.
Proposals do not require large amounts of preliminary data, but must have a clear hypothesis and research plan
to be completed within the two year grant term. This funding is intended primarily as seed money for promising
and potentially transformative new projects, rather than funding well-developed clinical projects that already
receive considerable support. However, high risk/high reward add-on studies leveraging larger ongoing projects,
or pre-existing data-sets, clinical samples, etc. are of interest. Investigators at all levels will be funded through the
Legacy Program and are encouraged to apply.
Amount: $100,000 over 2 years
Deadline: August 17, 2011
The Lustgarten Foundation: Cure Pancreatic Cancer Now
Correlative Studies Awards Program
The Lustgarten Foundation will fund selected correlative science proposals directly linked to a CTEP sponsored clinical trial of novel therapeutics for pancreatic cancer. These correlative studies will utilize the principles routinely applied to clinical diagnostic tests, including the use of appropriate pharmacodynamic (PD) endpoints, to develop assays that will provide robust and accurate measurements of drug effects in patient specimens. Any investigator eligible to receive support from CTEP and proposing to conduct CTEP-sponsored clinical trial of a novel therapy for pancreatic cancer will be eligible to apply for funding from Lustgarten for support of correlative studies related to the trial.
Amount: unspecified
Deadline: applications are accepted on a rolling schedule
All grants are due into the Office of Grants and Contracts five business days prior to the sponsor's deadline for DFCI review prior to submission to the sponsor. 
